Skip to content

A new amyloid-lowering therapy is now available for people living with early Alzheimer’s disease with the TGA registration of LEQEMBI (lecanemab)

By API User

Key Facts: VIDEO NEWS RELEASE AVAILABLE https://spaces.hightail.com/space/BqMWebJQnC MELBOURNE and SYDNEY, 24 September 2025 – Eisai Australia and Biogen Australia have announced today that the Therapeutic Goods Administration (TGA) has registered the use of LEQEMBI® (lecanemab) in Australia as an amyloid-lowering therapy in adult patients for the treatment of Mild Cognitive Impairment due to Alzheimer’s disease … Continued

Unlocking the immune system’s instruction manual

By API User

Scientists have uncovered how a key type of immune cell adapts its behaviour depending on the type of infection, paving the way for better vaccines and advancing research into immune-related diseases.  In a major study published in Nature Immunology, a WEHI-led research team revealed how T follicular helper (Tfh) cells tailor their instructions to the … Continued

Join Dr Kirsten Banks, Sean Wolpert, Dr Todd Bond and host Emily Jateff as they conquer the Earth’s final frontier: the deep sea

By API User

On October 16, the Australian National Maritime Museum is proud to present the third talk in its Big Blue Ideas series, Is The Deep Sea a Wasteland or Wonderland? Join astrophysicist and science communicator Dr Kirsten Banks, DEEP board member Sean Wolpert, and deep-sea ecologist Dr Todd Bond for an honest and open discussion into … Continued

New eyedrop formula in sight for serious vision problems

By API User

A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising hopes for less invasive treatment of serious vision conditions. The research led by RMIT University is focused on retinal diseases, especially age-related macular degeneration (AMD). AMD damages the retina, specifically the macula, which can cause … Continued

Breaking the ice: why study Antarctica?

By API User

Key Facts: From unique wildlife to resilient microbes, world-changing climate dynamics to untapped biotechnological potential – four UNSW scientists outline what makes Antarctica a laboratory like no other. Earlier this year, UNSW Sydney PhD candidate Christina Schmidt submitted her thesis – from the deck of Australia’s multi-billion-dollar icebreaker, just off the East Antarctic coast. Schmidt’s … Continued

‘Like talking on the telephone’: quantum computing engineers get atoms chatting long distance

By API User

Key Facts: UNSW quantum engineers have created quantum entanglement between two distant atoms in silicon using electrons as a bridge. UNSW engineers have made a significant advance in quantum computing: they created ‘quantum entangled states’ – where two separate particles become so deeply linked they no longer behave independently – using the spins of two … Continued

Monash invention progresses to Phase 3 clinical trial for treatment of advanced breast cancers

By API User

In a rare and significant milestone for an Australian-discovered therapy, Pfizer Inc has commenced a Phase 3 clinical trial to study a potential new medicine for advanced breast cancer, based on pioneering research from Monash University and the Cancer Therapeutics Cooperative Research Centre (CTx). The first-in-class therapy is being studied as a treatment in adults … Continued

AI reveals gender bias in family courts

By API User

Key Facts: When parents separate in Australia, their futures – and their children’s – often rely on the words chosen by judges in the Family Court. But those words aren’t always neutral along gender lines, say a team of UNSW researchers. The language chosen by judges in the Australian family courts reflects and reinforces long-standing … Continued

Helmholtz Munich and Parse Biosciences GigaLab Generate World’s Largest Human Lung Tissue Perturbation Atlas

By API User

Researchers aim to identify cellular circuit mechanisms and generate a dataset to fuel AI-driven foundational research of lung biology MUNICH & SEATTLE–BUSINESS WIRE– Helmholtz Munich and Parse Biosciences today announced a strategic partnership to generate the world’s broadest lung disease perturbation atlas, powered by Parse Biosciences’ GigaLab platform. Using a human lung ex-vivo tissue slice … Continued